Q32 Bio Inc. is scheduled to release top-line results from its Phase 2 SIGNAL-AD clinical trial today at 2:00 p.m. ET. The study evaluates the efficacy and safety of bempikibart, a monoclonal antibody designed to treat moderate-to-severe alopecia areata, an autoimmune condition characterized by patchy hair loss. Investors and the medical community are monitoring these … Read more
Robot Achieves Tennis Proficiency with Minimal Training Data The world of robotics continues to push boundaries and a recent breakthrough demonstrates a remarkable leap in artificial intelligence and motor skill learning. Researchers have developed a system that enabled a humanoid robot to play tennis – and ultimately defeat its human instructor – after being trained … Read more
“`html Increased Shark sightings in Sydney Linked to Heavy Rainfall Increased Shark sightings and Attacks in Sydney Linked to Heavy Rainfall Publication date: 2026-01-19 12:19:34 Updated: 2026-01-19 12:19:34 A bull shark (Carcharhinus leucas). Photo = Wikimedia Commons/pterantula Recent incidents in Sydney, Australia, including a serious shark attack in Sydney Harbour and a subsequent encounter on … Read more